LTRN
Price
$4.35
Change
+$0.36 (+9.02%)
Updated
Jul 17, 03:04 PM (EDT)
Capitalization
43.03M
20 days until earnings call
XOMAO
Price
$25.60
Change
+$0.10 (+0.39%)
Updated
Jul 16 closing price
Capitalization
N/A
Interact to see
Advertisement

LTRN vs XOMAO

Header iconLTRN vs XOMAO Comparison
Open Charts LTRN vs XOMAOBanner chart's image
Lantern Pharma
Price$4.35
Change+$0.36 (+9.02%)
Volume$229
Capitalization43.03M
XOMA
Price$25.60
Change+$0.10 (+0.39%)
Volume$381
CapitalizationN/A
LTRN vs XOMAO Comparison Chart in %
Loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LTRN vs. XOMAO commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a StrongBuy and XOMAO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (LTRN: $3.99 vs. XOMAO: $25.60)
Brand notoriety: LTRN and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 91% vs. XOMAO: 10%
Market capitalization -- LTRN: $43.03M vs. XOMAO: $0
LTRN [@Biotechnology] is valued at $43.03M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than XOMAO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 5 TA indicator(s) are bullish while XOMAO’s TA Score has 4 bullish TA indicator(s).

  • LTRN’s TA Score: 5 bullish, 3 bearish.
  • XOMAO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than XOMAO.

Price Growth

LTRN (@Biotechnology) experienced а +17.70% price change this week, while XOMAO (@Biotechnology) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.73%. For the same industry, the average monthly price growth was +13.25%, and the average quarterly price growth was +38.01%.

Reported Earning Dates

LTRN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LTRN YTD gains are higher at: 25.078 vs. XOMAO (6.155). XOMAO has higher annual earnings (EBITDA): 6M vs. LTRN (-21.24M). XOMAO has more cash in the bank: 93.3M vs. LTRN (19.7M). LTRN has less debt than XOMAO: LTRN (195K) vs XOMAO (114M). XOMAO has higher revenues than LTRN: XOMAO (13M) vs LTRN (0).
LTRNXOMAOLTRN / XOMAO
Capitalization43MN/A-
EBITDA-21.24M6M-354%
Gain YTD25.0786.155407%
P/E RatioN/AN/A-
Revenue013M-
Total Cash19.7M93.3M21%
Total Debt195K114M0%
TECHNICAL ANALYSIS
Technical Analysis
LTRNXOMAO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
20%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
21%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
20%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
24%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
21%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
18%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 3 days ago
22%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
11%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
18%
View a ticker or compare two or three
Interact to see
Advertisement
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOFI21.390.43
+2.05%
SoFi Technologies
TBRG21.670.28
+1.31%
TruBridge
DNOW14.510.11
+0.76%
DNOW
ATRA9.280.01
+0.11%
Atara Biotherapeutics Inc.
GAU1.38-0.02
-1.43%
Galiano Gold

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
+0.40%
AMLX - XOMAO
68%
Closely correlated
+3.82%
XOMAP - XOMAO
30%
Poorly correlated
-0.58%
ATAI - XOMAO
24%
Poorly correlated
+1.89%
LTRN - XOMAO
23%
Poorly correlated
+6.12%
KALV - XOMAO
23%
Poorly correlated
+4.09%
More